♟️ Wednesday 19 November 2025 Wed, 19 Nov 2025

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

Tasmea Limited has announced the acquisition of WorkPac Group for up to A$60.7 million, significantly enhancing its workforce solutions capabilities and positioning the company for growth amid Australia's skilled labour shortages.

Tasmea Limited reported a stellar FY25 with strong revenue and profit growth, bolstered by strategic acquisitions and a robust dividend payout. The company signals continued momentum with a new acquisition announcement and targets ASX300 inclusion in 2026.

Tasmea Limited reported robust FY25 financial results with a 74% jump in net profit after tax, driven by organic growth and strategic acquisitions. The company reaffirmed its FY26 guidance, supported by a $43 million institutional placement to fuel further expansion.

Conrad Asia Energy has partnered with PT Nations Natuna Barat to farm down a majority stake in the Mako gas field, securing full funding for its development and reducing capital risk. The deal positions Conrad to focus on other exploration assets while retaining operational control.

Schaffer Corporation delivered solid FY25 results with revenue growth and record property valuations, but the Jaguar Land Rover cyberattack clouds the near-term outlook for its Automotive Leather division.

Schaffer Corporation reported a 10% decline in statutory net profit for FY25, driven by mixed segment performances, while maintaining dividends and advancing key property developments.

ParagonCare reported solid FY25 results, progressing well on its complex merger integration and expanding its footprint in Asia through the acquisition of Somnotec Group.

GTN Limited reported a modest 2% revenue decline and a sharper 26% drop in adjusted EBITDA for FY25, while maintaining strong cash flow and delivering solid shareholder returns.

Nufarm Limited has announced Rico Christensen as its new CEO, succeeding Greg Hunt in January 2026, marking a strategic leadership transition with a focus on operational excellence and growth.

Stakk Limited has landed a pivotal 3-year contract with U.S. fintech giant SoFi, significantly boosting its annual recurring revenue projections beyond $8 million. This deal highlights Stakk’s growing footprint in embedded finance across major international brands.

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

Felix Gold's metallurgical testwork confirms ultra-high purity antimony concentrate from its Treasure Creek NW Array prospect, exceeding US military specifications and offering multiple processing pathways. This breakthrough could rapidly address critical US supply shortages amid geopolitical export bans.

LGI Limited reported robust FY25 results with a 14% rise in EBITDA and secured six new contracts, positioning the company for a 25-30% EBITDA increase in FY26. Key project completions and expansions underpin this momentum.

EML Payments has affirmed its FY26 underlying EBITDA guidance of A$58-63 million following a solid Q1 trading update, underpinned by a growing new program pipeline and operational efficiencies.

Silver Mines Limited has announced its best-ever mineralised diamond drill intercept at the Bowdens Silver Deposit, hitting 116 metres at 245g/t silver and significantly surpassing previous records. This breakthrough validates Bowdens as one of Australia’s premier undeveloped silver projects amid a backdrop of soaring silver prices.

Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.

Helloworld Travel has tabled a non-binding offer to acquire all remaining shares of Webjet Group at a 31% premium, aiming to create a stronger travel booking powerhouse.

Ridley Corporation reports solid FY25 earnings growth and outlines a diversified growth strategy for FY26, anchored by its recent Incitec Pivot Fertilisers acquisition.

Enegex Limited has completed its acquisition of Famien Resources and appointed Paul Roberts as Managing Director, signaling a strategic shift aimed at accelerating gold exploration efforts.

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

Osmond Resources has reported exceptional assay results from its first drill hole at the Orión EU Critical Minerals Project, confirming high-grade titanium, zircon, and rare earth mineralisation. The discovery positions the project as a significant potential supplier of critical minerals within the EU.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.